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Abstract
Paired immunoglobulin-like receptors beta, PILRb, and alpha, PILRa, are related to the Siglec family of receptors and are
expressed primarily on cells of the myeloid lineage. PILRb is a DAP12 binding partner expressed on both human and mouse
myeloid cells. The potential ligand, CD99, is found on many cell types, such as epithelial cells where it plays a role in
migration of immune cells to sites of inflammation. Pilrb deficient mice were challenged with the parasite Toxoplasma gondii
in two different models of infection induced inflammation; one involving the establishment of chronic encephalitis and a
second mimicking inflammatory bowel disease in order to understand the potential role of this receptor in persistent
inflammatory responses. It was found that in the absence of activating signals from PILRb, antigen-presenting cells (APCs)
produced increased amounts of IL-27, p28 and promoted IL-10 production in effector T cells. The sustained production of IL-
27 led ultimately to enhanced survival after challenge due to dampened immune pathology in the gut. Similar protection
was also observed in the CNS during chronic T. gondii infection after i.p. challenge again providing evidence that PILRb is
important for regulating aberrant inflammatory responses.
Citation: Tato CM, Joyce-Shaikh B, Banerjee A, Chen Y, Sathe M, et al. (2012) The Myeloid Receptor PILRb Mediates the Balance of Inflammatory Responses
through Regulation of IL-27 Production. PLoS ONE 7(3): e31680. doi:10.1371/journal.pone.0031680
Editor: R. Lee Mosley, University of Nebraska Medical Center, United States of America
Received July 13, 2011; Accepted January 16, 2012; Published March 27, 2012
Copyright:  2012 Tato et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study is funded by Schering Plough, now part of Merck and CO. This funder reviewed the progress of the project annually and as the authors are
employed by Schering Plough, the funders played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr.
Phillips is supported by National Institutes of Health (NIH) grant AI73756. The NIH had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors are empolyed by Schering Plough, now part of Merck and CO. No products in development or marketed products are to
declare. The studies were funded by Schering Plough and this does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: daniel.cua@spcorp.com
Introduction
Dap12 is a modulator of the amplitude of an immune response,
but in a very cell specific way [1]. There are many receptors that
pair with Dap12 whose expression patterns, in part help govern
the ultimate consequence of Dap12 signaling. One receptor
partner of Dap12 is the paired-immunoglobulin-like receptor-beta
(PILRb). PILRb is a type I glycoprotein with a single extracellular
Ig-like domain and a truncated cytoplasmic tail [2]. PILRb does
not contain its own activation motif, but is dependent on Dap12
for ITAM mediated signals. PILRa is the inhibitory form of the
receptor containing an ITIM within its intracellular domain that is
thought to bind SHP-1/2 upon phosphorylation [3] [2]. PILRa
and PILRb are mainly expressed on cells of the myeloid lineage in
both human and mouse populations, with most cells displaying
both isoforms of this receptor on their surface constitutively.
However, there is some differential expression between the paired
receptors, with PILRb as the primary isoform displayed by NK
cells [4]. Expression of both receptors has also been shown to be
upregulated on CNS-infiltrating macrophages and microglial cells
during experimental autoimmune encephalomyelitis (EAE) (Joyce-
Shaikh and Cua, unpublished data).
While expression of this paired receptor is relatively restricted, its
potential ligands have a considerably more ubiquitous expression
pattern. A CD99-like molecule was first identified on T cells as
interacting with PILRb on NK cells and activating their cytotoxic
capacity. [4]. The same group also found that the CD99-like
molecule was able to activate bone-marrow derived dendritic cells
(DCs) and promote TNFa production. Although the PILRs contain
a conserved arginine residue typical of Siglec family members, they
do not themselves bind simple sialylated sugars. Instead, the ability
of CD99 to bind PILRa and PILRb was characterized as involving
recognition of two O-glycosylated sites on CD99 and these sites are
thought to be essential for stable interaction between receptor and
ligand [5,6]. Despite the efficiency with which the activating
receptor is triggered by CD99 and CD99-like molecules, it was
discovered that the affinity of PILRa for CD99 binding is
significantly higher than the affinity of PILRb [5].
CD99 is a glycoprotein that is thought to modulate a number of
immune responses related to inflammation. It is expressed on the
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activated T cells [7]. It may also play a role in regulating the
migration of cells into tissues as it is also found on endothelial tight
junctions where it has been shown to mediate immune cell
extravasation from the blood [8,9,10]. Additionally, the inhibitory
receptor, PILRa, is also thought to act as a co-receptor for viral
glycoprotein B allowing pathogen entry into the host cell and in
some cases viral persistence [11,12]. There is an ever growing body
of evidence to suggest that the CD99:PILRa/b interactions have a
significant affect on the quality of the innate immune response.
However, little is actually known about the overall function of these
receptors or of their possible cross-regulation of each other.
Many DAP12 associated receptors have been shown to play key
roles in regulating immune responses of macrophages and DCs
during inflammatory responses. We therefore, used activating
receptor-deficient mice to study the relevance of PILRb in
immune function. Specifically, given the receptor/ligand pattern
of expression, we decided to employ two models of infection-
induced chronic inflammation by challenging mice via alternative
routes of infection with the protozoan parasite Toxoplasma gondii (T.
gondii). In this way, we were able to analyze how PILRb deficiency
may alter the function of inflammatory antigen presenting cells
(APCs) in tissues commonly targeted during autoimmune
inflammation; the CNS and the mucosa. Low dose intra-
peritoneal challenge with T. gondii promotes a systemic Th1
response during the acute phase of infection that serves to clear the
immediate infection, drives the parasite into latency, and allows for
pathogen persistence in the host’s CNS [13,14,15]. A susceptible
host will eventually succumb to toxoplasmosis, a chronic brain
inflammation that is the result of increasing recruitment of
immune cells into the brain to keep the parasite from reactivating.
Both infiltrating and CNS resident APCs are important for
maintaining the balance of pro- and anti-inflammatory mediators
during chronic infection [15,16].
Via high dose per oral infection with T. gondii, we were able to
establish a murine model of inflammatory bowel disease (IBD) to
test the impact of abrogating the function of PILRb [17]. This
route of infection promotes a robust Th1-type response that
precipitates an aggressive immune-mediated pathology, causing
necrosis of ileal villi, and resulting in the ultimate demise of the
host within 7–14 days after challenge [18]. This model of infection
mimics other IBD models with regard to immunological
mechanisms and histological changes. For example, it is known
that CD4+ T cells play a critical role in mediating pathology after
high-dose infection with T. gondii, and an aberrant response to
commensal flora worsens outcome. Thus, the innate immune
response greatly affects outcome and severity of disease by
establishing and then continuing to promote inflammation well
beyond the initiating injury.
Through the use of activating receptor deficient mice (Pilrb2/2)
we now show that APCs may use this receptor pair to balance the
production of pro- and anti-inflammatory cytokines during an
immune response. In the absence of PILRb, mice infected by either
route exhibited enhanced survival after parasitic challenge, which
was characterized by increased production of IL-27, but not IL-10.
APCs from PILRb2/2 mice exhibit a more tolerogenic phenotype




Pilrb2/2 mice were derived as previously described [19] were
bred and housed within micro isolator caging units on site at
MRL. Mice were bred as homozygous knockouts and wild-type
(WT) C57Bl/6 (Jackson Laboratories, Bar Harbor, ME) were used
as age- and sex-matched controls in all experiments. All animal
procedures were approved by the Institutional Animal Care and
Use Committee of Merck Research Laboratories in accordance
with guidelines of the Association for Assessment and Accredita-
tion of Laboratory Animal Care.
Parasites
For in vivo experiments, mice were inoculated either intra-
peritoneally with 20 cysts or per orally with 80–100 cysts of the
Me-49 strain of T. gondii. Brain homogenate from chronically
infected CBA/CaJ mice (Jackson Labs) were used as the source of
cyst preparations for inoculation.
Cyst counts
Individual brains from chronically infected mice were processed
in 3 ml of PBS using syringes and consecutive 18 G, 20 G and
22 G needles to create a homogenate. The number of cysts present
in 30 ml of homogenate was used to determine the total number of
cysts present within each brain.
Histology
Dissected brain or ileum were fixed in 10%NBF before
embedding in paraffin. Hematoxylin and eosin staining was
performed on sections of tissue for analysis of pathology.
Brain mononuclear cell isolation and culture
Brain mononuclear cells (BMNC) were isolated from the CNS
by performing collagenase digestion and separating lymphocyte
populations using a percoll gradient as previously described
[20,21]. Cells were plated at 2610
5 cells per well in complete
RPMI (Life Technologies, Gaithersburg, MD) supplemented with
10% FCS (HyClone Laboratories, Logan, UT), 1% HEPES,
50 mM 2-mercaptoethanol, 1% sodium pyruvate, and penicillin
and streptomycin for a final volume of 200 ml. Cultures were
stimulated with either aCD3 at 5 mg/ml or soluble Toxoplasma
antigen (STAg) at 20–25 mg/ml (generous gift of C.A. Hunter,
University of Pennsylvania, Philadelphia, PA).
Splenocyte and lymph node culture
Spleens or LNs were harvested and dissociated into single-cell
suspensions in complete RPMI as above. Erythrocytes were
depleted from splenocyte suspensions using RBC Lysing Buffer
(Sigma, St. Louis, MO), and cells were washed in complete media.
Cells were plated at either 4610
5 or 2610
5 cells per well for
splenocytes or LNs, respectively, and for a final volume of 200 ml.
Cells were cultured as above for analysis of cytokine production
after 2–3 days of restimulation at 37uC.
APC enrichment
Magnetic cell sorting was performed to enrich populations of
splenic dendritic cells (CD11c (N418) microbeads) and macro-
phages (CD11b microbeads), respectively from mice 5 days post
i.p. parasite or PBS challenge using the standard protocols from
Miltenyi Biotec (Auburn, CA). Cells were sorted using an
autoMacs Separator according to the standard protocol. Cell
pellets were used for RNA isolation and analysis of gene transcripts
by RT-PCR (see below).
Cytokine protein quantification
Serum samples or supernatants from cell culture were analyzed
for cytokine protein levels using either ELISA kits for IFNc, IL-
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LincoPlex (LINCO Research) for TNFa.
Vector construction
The p2øC31.RSV.hAAT.bpA plasmid was provided by Dr.
Zhi-Ying Chen (Stanford University, Stanford, CA). The vector
was modified and a unique 59 PmeI and 39 PacI restriction sites
flanking hAAT was introduced to facilitate directional cloning of
cDNA’s. PCR amplification was performed to place 59 PmeI and
39 PacI cloning sites on the mEBI3, mp28 and linked mIL-27
cDNA’s and these were ligated with the modified minicircle
producing vector. All constructs were verified by restriction
digestion and sequencing of the cloned insert and flanking region.
Production of minicircle DNA
Mini-circle DNA was produced following the methods de-
scribed with some minor modifications [22]. For overnight
cultures 1 liter of Terrific broth containing 100 ı `g/ml Ampicillin
was inoculated and incubated 18 hrs shaking at 270 rpm.
Following the minicircle production method cultures were
precipitated and stored at 280 C. Endotoxin free Qiagen
megaprep kits were used for DNA purification, with 120 ml
volumes of solution P1, 2&3. Minicircle DNA was eluted from the
column, isopropanol was added and stored at 220 C. DNA was
precipitated by spinning at 12 K, 309 at 4 C, rinsed with 70%
ethanol, air dried and resuspended in 1 ml of endotoxin-free Tris
EDTA. Minicircle DNA was dialyzed in Midi MWCO 3.5 kDa
tubes overnight against Tris EDTA. Purified minicircle DNA was
verified by restriction digestion and sequencing.
Minicircle Delivery
Minicircles were administered using a hydrodynamics-based
transfection procedure as described previously [23]. Briefly, 20 mg
of minicircle DNA in 2 ml of Ringer’s solution was administered
via tail vein injection within 5–8 seconds. Systemic expression of
specific transgenes was verified using ELISA to analyze peripheral
blood at various time points.
RNA isolation and real-time quantitative PCR
Total RNA was extracted from dissected tissue by homogeniz-
ing organs into RNA STAT-60 (Tel-Test) using a polytron
homogenizer, and following manufacturer’s instructions. After
isopropanol precipitation, total RNA was re-extracted with
phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma-Aldrich) using
phase-lock light tubes (Eppendorf). For cell pellets, RNA was
isolated using the RNeasy method, according to the manufactur-
er’s protocol (Qiagen). Total RNA was reverse-transcribed using
QuantiTect (Qiagen) according to manufacturer’s instructions.
Primers were obtained commercially from Applied Biosystems.
Real-time quantitative PCR was performed using an ABI 7300 or
7900 sequence detection system. The absence of genomic DNA
contamination was confirmed using primers that recognize
genomic region of the CD4 promoter. Quantities of transcripts
encoding ubiquitin were measured in a separate reaction and used
to normalize the data by the –Ct method [24].
Parasite burden analysis. For parasite burden analysis,
mesenteric lymph nodes or spleen were harvested on D3 or D9
post infection and flash frozen. Tissues were homogenized in
Trizol (Invitrogen) reagent to extract RNA followed by cDNA
synthesis using Superscript III First-Strand Synthesis System
(Invitrogen) according to manufacturer’s instructions. Gene
expression was monitored by real-time PCR using Taqman
primer/probe sets (Applied Biosystems) for mouse b-actin and
Toxoplasma Sag1. Data was collected on the Mx3000P Q PCR
System (Agilent Technologies).
Statistical Analysis
Student’s t-test was performed for analysis of significance and all
results are expressed as mean 6 SEM, unless otherwise noted. P
values are presented where statistical significance was found.
Results
PILRa/b modulate CNS inflammation during chronic
infection after i.p. challenge with T. gondii
Data from previous experiments performed in our laboratory
showed that mRNA expression of both PILRs was increased inCNS
resident microglial cells 14 days after induction of experimental
autoimmune encephalomyelitis (EAE), the mouse model of Multiple
Sclerosis compared to expression at day 0 (Fig. S1a). Therefore, to
test whether activating receptor deficient APCs were capable of
modulating responses in an infection-induced model of CNS
inflammation, C57BL/6 WT and gene deficient mice were infected
intra-peritoneally (i.p.) with 20 cysts of the Me-49 strain of T. gondii
and followed out for 100 days. We first determined if there was
normal expression of PILRa in the absence of PILRb compared to
WT mice during toxoplasmosis. When brain mononuclear cells
(BMNCs) were harvested from chronically infected mice 60 days
after challenge, and analyzed by RT-PCR for receptor expression,
both WT and Pilrb2/2 mice exhibited similar levels of PILRa
inhibitory receptor (Fig. S1b). As expected, the PILRb-activating
receptor mRNA was detected in the WT mice, but was absent in
gene-deficient mice following parasite infection.
When compared for survival, the WT C57BL/6 mice—which
are susceptible to infection—began succumbing between 60 and
90 days post-challenge, whereas Pilrb 2/2 mice remained
resistant beyond 100 days post infection (Fig. 1a). In addition,
histological examination of the brain from chronically infected
mice confirmed the presence of more inflammatory infiltrate in
WT compared to Pilrb 2/2 brain, suggesting that the enhanced
resistance in Pilrb2/2 mice is due to reduced immunopathology
associated with fewer CNS infiltrating cells (Fig. 1b).
In order to better characterize the mechanism behind this
enhanced survival, either whole brain or BMNCs were isolated
from both groups after 60 days of infection and parasite burden
and inflammatory infiltrate were quantified. Cyst counts revealed
significantly lower pathogen load in the activating receptor
Pilrb2/2 mice compared to WT controls (Fig. 1c). When
BMNCs isolated from chronically infected mice were examined by
flow cytometry, no difference in types of infiltrating cells, or
percentages of cell population were observed between strains (data
not shown). However, when actual numbers of infiltrating cells
were determined, we found that Pilrb2/2 mice had significantly
fewer numbers of BMNCs corresponding to enhanced resistance
to encephalitis (Fig. 1d).
Chronic resistance to toxoplasmosis requires a delicate balance
between pro-inflammatory cytokines like IFNc and TNFa to
control infection and regulatory cytokines like IL-10 to prevent
immunopathology [25]. Therefore, we isolated BMNCs from
chronically infected mice and determined if there was a difference
in production of cytokines. In response to aCD3 restimulation there
was significantly more TNFa and IFNc protein detected in the
supernatants of Pilrb 2/2 cultures compared to WT cultures
(Fig. 1e and f). One would have expected more inflammatory
cytokine production in WT cultures given that WT mice have a
higher parasite burden than Pilrb 2/2mice at the same time-point.
More IFNc production in Pilrb 2/2 mice would also suggest the
PILRbeta Regulates IL-27 Production in APCs
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revealed fewer cells infiltrating the CNS. One explanation for this
paradoxisthattheenhanced IFNc productioninthe Pilrb2/2may
lead tobettercontrolofparasitereactivation,andthusbettercontrol
of parasite numbers. Nitric oxide production in the CNS is an
important mechanism of pathogen control during chronic infection,
however when nitric oxide levels were analyzed in BMNC cultures,
no difference was seen under any condition (Fig. 1g). Higher levels
of inflammatory cytokine production would need to be balanced by
regulatory cytokines in order to keep CNS inflammation subdued.
Previously published studies have assigned IL-10 an important role
in controlling CNS inflammation during chronic toxoplasmosis
[15,26,27]. When IL-10 production was assessed in BMNC
cultures, significantly greater levels were detected in Pilrb 2/2
BMNCculturesnotonlyinresponsetoaCD3,butalsoafterantigen
restimulation over amounts produced in WT cultures (Fig. 1h).
These data again suggested that Pilrb2/2 APCs promote IL-10
secretingT effectorcellsthathometotheCNSand providedamore
stringent regulation of inflammation in the CNS. However, the
enhanced production of anti-inflammatory cytokines did not
preclude the possibility that Pilrb 2/2 mice may also have an
increased ability to clear the parasite from the local site of infection
during the acute response.
Increased systemic IL-27p28, but decreased IFNc in Pilrb
2/2 mice after i.p. infection
In order to characterize the acute immune response to infection
with T. gondii, both WT and Pilrb deficient mice were infected i.p.
as before and lymphocyte responses were analyzed at various
timepoints during the first two weeks post challenge. When serum
from day 5-infected mice were tested for inflammatory cytokines,
systemic IL-12 production was similar. However, circulating IFNc
was reduced in Pilrb2/2 mice (Fig. 2a and b). Although serum
IL-10 was enhanced in both WT and Pilrb 2/2 mice after
infection, there was no difference between strains (Fig. 2c).
Interestingly, the reduction in IFNc production did not have a
deleterious effect on controlling infection, because analysis of day
3- and day 5-peritoneal exudate cells (PECs) revealed no
differences in parasite burden between strains (Fig. S2a). Since
there were no obvious differences in the acute phase activation of
the immune response to T. gondii, we wondered whether there
might be differences in other regulatory cytokines at this early
timepoint.
It has been recently shown that the presence of IL-27 can
directly induce a strong regulatory effect on CD4 T cell
production of proinflammatory cytokines, an effect that can also
be mediated by enhancing IL-10 production [28,29,30] [31] [32].
Specifically in the context of infection with T. gondii, IL-27 has
been shown to play a significant role in regulating Th1 activation
and preventing immunopathology (reference 30). Given that
effector T cells from Pilrb2/2 mice have an increased propensity
for secreting IL-10, we assessed the production of IL-27 in WT
and Pilrb deficient mice after i.p infection as a potential mechanism
for the enhanced resistance to toxoplasmosis. Thus, IL-27 was
analyzed in the serum of both acute and chronically infected mice
after infection. Interleukin-27 is not constitutively expressed, as no
Figure 1. Characterization of the local inflammatory response during chronic i.p. infection. WT and Pilrb 2/2 mice were challenged i.p.
with 20 cysts T.gondii and followed over time. Survival of WT and Pilrb2/2 mice through 100 days post infection (a). H&E of brain sections reveal
larger inflammatory foci in WT mice compared to Pilrb2/2, shown at 106magnification (b). Total number of cysts present in the CNS of mice 60–90
days post infection (c). Actual numbers of BMNCs isolated from the CNS of mice (d). Recall assays using BMNCs isolated from WT and Pilrb2/2 mice
and cultured for 72 hrs in the presence of Media alone, STAg, or aCD3. Levels of protein are shown as detected by ELISA for TNFa (e), IFNc (f), NO (g),
and IL-10 (h). For panel a, n=5–15 mice/group for each of 3 experiments performed. For panel c, pooled data from 2 experiments are shown,
p,0.004. For panel d, one representative experiment of 2 is shown, p,0.05. For panels e,f, and h, pooled data from 2–3 experiments are shown,
*p,0.005; **p,0.002.
doi:10.1371/journal.pone.0031680.g001
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either WT or Pilrb2/2 mice injected with PBS alone. While levels
of IL-27p28 were increased in both strains by 5 days post infection,
there were significantly higher levels present in serum from Pilrb
2/2 mice than from WT mice (Fig. 2d). Interestingly, systemic
production of IL-27p28 did not lead to a corresponding increase in
IL-10 protein at this early day 5 time point, as there was no
detectable serum IL-10 in either strain (data not shown).
Additionally, production of IL-27p28 was found to be maintained
throughout the course of infection in both WT and KO mice, even
at day 60 post infection (Fig. 2e). Once again significantly higher
levels of p28 were found in the serum of chronically infected Pilrb
2/2 mice compared to WT mice. It may be predicted that the
p28 expression that is present early during infection could enhance
the early Th1 response in Pilrb 2/2 mice and allow for more
efficient clearance of the parasite. Thus, there would be less of a
requirement for sustained IFNc expression under such conditions.
Pilrb 2/2 survive lethal high dose infection with T. gondii
Another model in which IL-10 production is important in
mediating resistance is an infection induced model of IBD, in
which a lethal inflammatory response persists in the ileum after per
oral administration of high dose T. gondii [33]. In order to test the
impact of the absence of Pilrb on APCs under these conditions,
mice were per orally challenged with 80–100 cysts of Me-49 and
survival was monitored. To establish whether or not the PILRs
were expressed in the mucosa during infection, sections of terminal
ileum from infected mice were analyzed by RT-PCR to track the
expression of PILRa and PILRb over time. Messenger RNA for
both the inhibitory and activating forms of the receptor were
found to increase significantly in the gut of WT mice by day 7 post
infection (Fig. 3a, b). As expected, no Pilrb expression was
detectable in gene deficient mice, however there was greater Pilra
expression observed in the ileum of Pilrb 2/2 mice compared to
that of WT mice by day 5 (Fig. 3b). These data suggest that there
is an earlier upregulation of the inhibitory receptor in the absence
of its activating partner. Furthermore, it was found that WT mice
succumbed to infection within 14 days of challenge with only 48%
survival on average, Pilrb 2/2 mice survived significantly longer,
with 87% survival (Fig. 3c).
Early differences in parasite burden may have an effect on the
magnitude of inflammation that is established gut. In order to
determine if there were differences in parasite load after high-dose
infection, we used qPCR to quantitate the amount of parasite
DNA in the mesenteric lymph nodes (MLN) and spleen 3 and 9
days post-infection, respectively. Again, we found no difference in
the MLN at the earliest timepoint of 3 days after infection (Fig.
S2b). Later by day 9, however, Pilrb2/2 spleens show decreased
parasite burden compared to WT spleens and this is consistent
with what we observed during chronic i.p. infection (Fig. 2b).
Locally, inflammation can also be regulated by cellular recruit-
ment to the tissue and the resultant milieu of cytokines. To
determine whether PILRa/b signaling can indeed affect either of
these aspects of the immune response, histological analysis of ileum
from both WT and Pilrb 2/2 mice after infection was performed.
Overall, WT sections of ileum revealed the presence of more
Figure 2. Systemic cytokine response in WT and Pilrb 2/2 mice after acute and chronic i.p infection. WT and Pilrb 2/2 mice were
challenged i.p. with either PBS or T.gondii and serum cytokine protein levels were determined by ELISA during acute infection; IL-12p70 (a), IFNc (b),
IL-10 (c), and IL-27p28 (d) all on day 5. Alternatively, IL-27p28 was analyzed on day 60–90 after challenge (e). Pooled data from 2–3 experiments is
shown for all graphs. For panel b, p,0.043; for panel d, p=0.0007 and for panel e, p,0.01.
doi:10.1371/journal.pone.0031680.g002
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deficient sections 10 days after challenge (Fig. 3d). When serum
levels of cytokine were analyzed at regular intervals during the first
7 days of infection there were, surprisingly, no significant
differences in systemic IL12p70 or IFNc production between
strains at any time point (Fig. 3e, and f).
Enhanced host survival of Pilrb 2/2 to lethal infection is
associated with increases in IL-27p28
To examine the function of effector cells after infection, MLNs
and spleens were harvested and cultured in recall assays at days 5
or days 7 and 10 post-infection, respectively, and supernatants
were analyzed for the presence of cytokine. Neither IFNc nor IL-
10 production by T cells was found to be significantly different
between cultured WT and Pilrb deficient MLNs (Fig. 4a)o r
splenocytes in response to soluble Toxoplasma antigen (STAg) or
aCD3 restimulation at any timepoint (Fig. 4b and c).
Thus, our data suggests that the resistance of Pilrb2/2 mice to
intestinal necrosis during high dose T. gondii infection is not due to a
consistently observed alteration of T cell effector cytokines during
inflammation. Importantly, since Pilrb is not expressed on T cells,
the mechanism by which this receptor modulates inflammationmay
not be T cell specific. It was therefore proposed that there must be a
change in the quality of APC activation either because of altered
cytokine production and/or a cell contact-dependent mechanism.
We next analyzed the production of IL-27, both systemically and
after antigen recall. We found that serum IL-27p28 levels were
increased by day 5 and 7 in the Pilrb 2/2 mice compared to WT
(Fig. 4d). In order to further characterize the cytokine milieu
present during early T cell activation, IL-27p28 production was
measured in MLN cultures after 5 days of infection. In response to
both antigen or aCD3 stimulation IL-27p28 was again found to be
increased in the absence of Pilrb compared to WT cells (Fig. 4e).
Taken together these data suggested that in the absence of Pilrb,
enhanced production of IL27p28 may likely lead to a more efficient
control of inflammatory T cells and increased host survival to lethal
immune-pathology. Therefore, in the absence of receptor activa-
tion, APCs may become more tolerogenic in phenotype and
promote a tighter regulationof the resultant inflammatory response.
Figure 3. Normal systemic response to infection, but enhanced resistance to high dose per oral infection. Expression of Pilrb (a) and
Pilra(b) mRNA in the ileum of infected WT and Pilrb 2/2 mice at various timepoints after infection. Survival of WT and Pilrb2/2 mice after high dose
oral infection, n=8–11 mice/group for each of 3 experiments performed (c). H&E of ileum sections from WT (top panels) and Pilrb2/2 (lower panels),
at day 0 (56) or day 10 post-peroral challenge 56and 206magnification, respectively. Arrows indicate the presence of blood (d). Levels of cytokine
protein present in the serum of naı ¨ve or infected mice at various timepoints, IL-12p70 (e) and IFNc (f).
doi:10.1371/journal.pone.0031680.g003
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the absence of PILRb signaling
Since PILRb is expressed on many myeloid subsets, we
undertook experiments to identify which cells were the main
source of IL-27p28 in our model. RT PCR of splenic APC
populations isolated after i.p. parasitic challenge, revealed
increased p28 mRNA in DCs from Pilrb2/2 mice compared to
WT mice, but no difference in EBi3 message (Fig. 5a,b). In
contrast, macrophages from gene deficient mice exhibited lower
message levels for both IL-27 sub-units compared to those isolated
from WT mice. We also observed increased mRNA for IL-10 in
Pilrb2/2 DCs compared to WT populations (Fig. 5c), however,
there were less consistent levels of IL-10 message present in
macrophage populations. Similar levels of PILRa message were
present in both WT and Pilrb2/2 strains for each APC
population making it unlikely that a compensatory upregulation
of the inhibitory receptor had occurred in the absence of the
activating receptor for either DCs or macrophages (Fig. S3).
Thus, these results suggest that by producing higher levels of IL-
27, the DC population may be able to influence the strength of the
inflammatory response despite high levels of inflammatory
cytokines. These data reveal that when PILRb signaling is
abrogated, DCs and possibly macrophages may become more
tolerogenic in phenotype by producing significantly more IL-
27p28 and in turn are better able to influence the overall potency
of the inflammatory response.
IL-27 and not p28 alone is required to mediate resistance
to challenge with T. gondii
Because it is only possible to detect p28 protein in serum and
supernatant samples, we tested if it was indeed IL-27, and not p28
alone that could mediate enhanced resistance to infection in the
Pilrb2/2 mice. We injected DNA plasmids to induce over
expression of either p28, EBi3 or a linked hyperkine form of IL-27
protein in C57Bl/6 mice before high dose per oral pathogen
challenge. When mice were monitored for survival it was found
that deaths occurred in all control groups beginning at day 8 post-
infection, but not in the IL-27-expressing group, suggesting a
direct role for IL-27 in mediating resistance (Fig. 6a). When
serum levels of p28 were tracked, it was found that p28 was
expressed over a log greater compared to the p28 protein in the
IL-27-expressing group. Notably, the levels of p28 protein in the
IL-27-expressing group were significantly higher compared to
control groups (Fig. 6b). Interestingly, in the presence of robust
IL-27 expression we also observed a greater induction of IL-10 in
the serum of IL-27-expressing mice by day 7 post-infection
compared to control or p28-expressing mice (Fig. 6c), while
systemic IFNc protein was similar between all groups (Fig. 6d).
Taken together these data provide evidence for a direct link
between IL-27, the promotion of systemic IL-10 and the enhanced
survival of mice after challenge.
Discussion
DAP12 has been shown extensively to regulate the inflamma-
tory responses of innate immune cells (reference 1). Like others, we
have shown here that interruption of DAP12 signaling results in
the increased production of both IFNc and IL-10 and decreased
activation of both macrophages and DCs [34]. However, our
observations are unique in that for our system the immune
response is significantly altered with the elimination of only one
DAP12 partner, through the deletion of PILRb, keeping all other
signaling pathways in tact. Thus, the effect we have observed may
Figure 4. Host survival is characterized by increased capacity to produce IL-27p28. Recall assays using MLNs at day 5 (a); and splenocytes
at day 7 (b and c, left panels) or day 10 (b and c, right panels) after peroral challenge. Amount of IFNc (a, top graph; and b, left and right) or IL-10 (a,
bottom graph; and c, left and right) detectable in supernatants of WT (grey bars) and Pilrb2/2 (black bars) after 3 days of culture in media alone, with
STAg, or with aCD3. For panel a, one representative experiment of two shown; for panels b and c, combined data from 3 independent experiments
shown. Time course of IL-27p28 protein in serum from infected WT (grey bars) and Pilrb 2/2 (black bars) mice as detected by ELISA, mean 6 SD is
shown (d). Values between strains on days 5, p=0.0219 and 7, p=0.0318 are all significantly different. Recall assay using MLNs at day 5 post-peroral
infection and cultured as above. Amount of IL-27p28 detectable in supernatants after 3 days of culture (e). Mean 6 SD are shown. For STAg,
p=0.0143; for aCD3, p=0.0371.
doi:10.1371/journal.pone.0031680.g004
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recently shown to regulate immune responses, such as the
downstream effects of IL-27.
Previously published work has identified IL-27 as having a
significant influence on the balance between an effective immune
response and curbing of immune pathology [35]. IL-27 produced
by myeloid cells has been shown not only to promote Th1
responses during an acute response to infection, but also to be
required for damping of effector cell responses during the late
adaptive stage of infection once the pathogen is controlled
[29,36,37,38]. The pleiotropic effects of IL-27 are also evident
in the data presented here. Despite a decrease in systemic IFNc
production after i.p. challenge, Pilrb deficient mice had no issue
clearing the parasite from the local site of infection. Importantly,
systemic IL-10 production was not different at early time points,
but comes up later in the response and is likely derived from T-
cells. When activated T cells were restimulated with either antigen
or aCD3, they were capable of normal IFNc as well as IL-10
production. This combination provides for adequate protection
against the parasite during acute infection while sustaining tight
regulation of the chronic inflammatory response in the CNS. We
have shown that PILRa and PILRb are expressed not only on
inflammatory macrophages and DCs, but also CNS resident cells
such as microglial cells. Interestingly, it is already known that cells
native to the CNS, such as microglia and astrocytes produce IL-27
under some conditions of inflammation [39,40,41]. These
expression data, along with our observations that the systemic
responses are not greatly altered in Pilrb2/2 mice after challenge,
may suggest that PILRa and PILRb primarily play a role in
regulating local inflammatory responses.
To test this idea we compared survival of WT and Pilrb 2/2
mice after high dose per oral infection, where better control of
local inflammation would be beneficial. Susceptibility in this case is
the result of immune mediated destruction of the mucosa by IFNc-
secreting CD4+ T cells and is independent of systemic infection
[42,43]. Again, while the acute, systemic response to high dose
infection was not altered, the data we have presented here suggest
that the absence of Pilrb significantly changes the local inflamma-
tion in the gut and allows for decreased epithelial damage and
enhanced survival that is directly mediated by IL-27. Furthermore,
we show specifically that DCs deficient for the activating receptor
PILRb express more IL-27 message and exhibit a more regulatory
phenotype with the capacity for efficient damping of the T effector
cell response.
Effector T cell responses to T. gondii have been shown to involve
the generation of IFNc/IL-10 double positive cells that are
required for preventing the immunopathology in response to the
parasite [44]. As previously discussed, IL-10 production is vitally
important for a limited mechanism of resistance after high-dose
per oral challenge with T. gondii, similar to its’ regulatory role in
IBD. Furthermore, there is an ever-increasing body of literature
showing IL-27-dependent upregulation of IL-10 as a mechanism
Figure 5. Cytokine mRNA expression in dendritic cells and macrophages from infected mice. Populations of DCs and macrophages were
enriched from the spleens of WT and Pilrb 2/2 mice 5 days after i.p. challenge. Cells were then analyzed by RT-PCR for mRNA levels of IL27p28 (a)
EBi3 (b) and IL-10 (c). Pooled data from one of two representative experiments is shown.
doi:10.1371/journal.pone.0031680.g005
Figure 6. IL-27 can mediate resistance to parasite induced immunopathology. Expression of p28, EBi3, IL27 hyperkine, or GFP control were
induced in vivo using minicircle DNA for systemic expression prior to high dose peroral infection with T. gondii. Survival curve of all groups 14 days
post infection (a), p,0.02 for IL-27 vs. eGFP treatment groups. Serum cytokine levels for each treatment group at day 0 (white bars) and day 7 (black
bars) post infection showing IL-27p28 (b), IL-10 (c), p,0.004, and IFNc (d). For all panels means 6 SD are shown. For panel a, n=5 or 10 mice/group
for each of 3 experiments performed. For panels b, c and d, n=10 mice/group for the experiment shown, 2 total experiments performed.
doi:10.1371/journal.pone.0031680.g006
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secretion by APCs can be modulated through ligation of the
PILRa and PILRb receptors, we cannot eliminate the possibility
that IL-10 may also contribute to the increased survival we
observed after peroral infection.
In a normal host, initial ligation of the more highly expressed
PILRb leads to activation of APCs as they migrate into target
tissues during the early inflammatory response. This first
interaction promotes a proinflammatory milieu due in part to
high levels of IL-12 secretion and lower levels of IL-27. As APCs
become activated, they are able to increase the amount of
inhibitory PILRa on their surface, and with its higher affinity for
CD99-like molecules, may then out-compete the activating
receptor for ligand. This change may cause a corresponding
change in levels of IL-27 production by APCs, and possibly a
corresponding increase in IL-10 production by activated T cells at
the site of inflammation which together serve to down-regulate the
inflammatory response. Thus, PILRa provides a negative feedback
loop for the activating effects of PILRb.
Related to its suppressive affects on Th17 cells it has been
recently shown that IL-27 can ameliorate inflammation and
pathology associated with experimental autoimmune encephalo-
myelitis (EAE) and collagen induced arthritis (CIA), murine
models of multiple sclerosis and rheumatoid arthritis
[45,46,47,48]. Thus, we have provided evidence for the first time,
that the PILRa/b receptor pair may directly promote a more
tolerogenic phenotype and be a possible target for altering the
local proinflammatory environment in both the mucosa and CNS.
Supporting Information
Figure S1 Expression as determined by RT-PCR, of
Pilra (a, left panel) and Pilrb (a, right panel) in
microglial cells 14 days after induction of EAE or in
BMNCs from mice infected with T. gondii for 60–90 days
(b, left and right panels, respectively).
(TIFF)
Figure S2 Parasite burden after infection with T.
gondii. Percentage of infected cells in the PECs of WT and
Pilrb2/2 mice 5 days after i.p. challenge (a). Toxoplasma titer was
monitored by transcript levels of SAG1 3 days post infection in the
MLN at day 3 (b, left panel), and spleen at day 9 (b, right panel)
from WT and Pilrb2/2 mice after peroral challenge with a high-
dose of T. gondii. For each organ SAG1 transcript was normalized
to mouse b-actin and the mean and standard deviation of 3 or 4
mice per condition is shown. Day 3 p=0.146; Day 9 *p=0.042.
(TIFF)
Figure S3 Inhibitory receptor, Pilra mRNA expression
in dendritic cells and macrophages. Populations of DCs and
macrophages were enriched from the spleens of WT (open bars)
and Pilrb 2/2 mice (black bars) 5 days after i.p. challenge. Cells
were then analyzed by RT-PCR.
(TIFF)
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